KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Liabilities and Shareholders Equity (2016 - 2025)

Globus Medical's Liabilities and Shareholders Equity history spans 15 years, with the latest figure at $5.3 billion for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 0.97% year-over-year to $5.3 billion; the TTM value through Dec 2025 reached $20.1 billion, down 1.01%, while the annual FY2025 figure was $5.3 billion, 0.97% up from the prior year.
  • Liabilities and Shareholders Equity reached $5.3 billion in Q4 2025 per GMED's latest filing, up from $5.1 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $5.4 billion in Q3 2023 to a low of $1.7 billion in Q1 2021.
  • Average Liabilities and Shareholders Equity over 5 years is $3.5 billion, with a median of $3.5 billion recorded in 2023.
  • Peak YoY movement for Liabilities and Shareholders Equity: skyrocketed 170.98% in 2023, then decreased 5.04% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $2.0 billion in 2021, then grew by 6.07% to $2.1 billion in 2022, then soared by 144.98% to $5.1 billion in 2023, then grew by 3.26% to $5.3 billion in 2024, then increased by 0.97% to $5.3 billion in 2025.
  • Per Business Quant, the three most recent readings for GMED's Liabilities and Shareholders Equity are $5.3 billion (Q4 2025), $5.1 billion (Q3 2025), and $5.0 billion (Q2 2025).